Scholars Central

Short communicationPublished 19 Sep 2020

Predictive, Precise, Personalized and Prognostic Medicine for NAFDL, NASH and Liver Cancers in Sub-Saharan Africa: Challenges, Solutions and Perspectives

Authors: Benjamin LONGO MBENZA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Five P Medicine (Predictive, Personalized, Preventive, Participating, and Precise, Evidence-Based) for the Management of NAFDL, NASH, Fibrosis, Compensated Cirrhosis, Liver Cancer, HCC Risk and Prognosis, is well established in Rich Western Countries. However, Innovations and Artificial Intelligence such as Glycomics, Genomics, Molecular biology are lacking in Democratic Republic of the Congo (DRC). Abstract: Thus, this lecture of the Art reports the natural history, the pathogenesis, and the prognostic value of Metabolic Hepatic Steatosis (NAFDL and NASH) for Subclinical Hypothyroidism with Insulin Resistances, Metabolic Syndrome, Ischemic Atherosclerosis, Type 2 Diabetes Mellitus, and HCC Complex Liver diseases (CLD) among Central Africans in Kinshasa from 2000 to 2018.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Archives of Surgical Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Surgical Oncology
  • SubjectOncology & Cancer
  • SubjectSurgery
  • BylineArticles whose byline prints “Benjamin LONGO MBENZA”